{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:55:52Z","timestamp":1781571352946,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T00:00:00Z","timestamp":1775952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007941","name":"Addis Ababa University","doi-asserted-by":"crossref","award":["RD\/PY-597\/2024"],"award-info":[{"award-number":["RD\/PY-597\/2024"]}],"id":[{"id":"10.13039\/501100007941","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"DOI":"10.1186\/s12981-026-00878-1","type":"journal-article","created":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T08:33:37Z","timestamp":1775982817000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Poor adherence to second-line antiretroviral therapy and its contributing factors among people living with HIV in Addis Ababa, Ethiopia"],"prefix":"10.1186","volume":"23","author":[{"given":"Bekelech Bayou","family":"Feyissa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abay","family":"Sisay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anteneh","family":"Yalew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Setswe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,12]]},"reference":[{"key":"878_CR1","unstructured":"FMOH Ethiopia. National Consolidated Guidelines for Comprehensive Hiv Prevention, Care and. Fmoh. 2018;1\u2013238."},{"key":"878_CR2","unstructured":"The Joint United Nations Programme on HIV\/ AIDS. Unaids Data 2023. UNAIDS. 2023;1\u201338."},{"key":"878_CR3","doi-asserted-by":"publisher","first-page":"697","DOI":"10.2147\/HIV.S278603","volume":"12","author":"A Seid","year":"2020","unstructured":"Seid A, Cherie N, Ahmed K. Determinants of virologic failure among adults on second line antiretroviral therapy in wollo, amhara regional state, northeast ethiopia. HIV\/AIDS - Res Palliat Care. 2020;12:697\u2013706.","journal-title":"HIV\/AIDS - Res Palliat Care"},{"key":"878_CR4","unstructured":"World Health Organization. International statistical classification of diseases and related health problems. Fifth. 2016;2."},{"key":"878_CR5","unstructured":"World Health Organization. March 2014 supplement to the 2013 consoildated guideline on USe of Antiretroviaral Drugs for Treating and Preventing HIV Infection. 2014. http:\/\/www.who.int\/hiv\/pub\/guidelines\/arv2013\/arvs2013upplement_march2014\/en\/"},{"issue":"1","key":"878_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-022-08606-x","volume":"22","author":"M Lahai","year":"2022","unstructured":"Lahai M, Theobald S, Wurie HR, Lakoh S, Erah PO, Samai M, et al. Factors influencing adherence to antiretroviral therapy from the experience of people living with HIV and their healthcare providers in Sierra Leone: a qualitative study. BMC Health Serv Res. 2022;22(1):1\u20139. https:\/\/doi.org\/10.1186\/s12913-022-08606-x.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"878_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1524-4733.2007.00213.x","volume":"11","author":"A Joyce","year":"2008","unstructured":"Joyce A, Cramer A, Roy A, Burrell CJ, Fairchild, Mahesh J, Fuldeore, Daniel A, Ollendorf PKW. Medication compliance and persistence: Terminology and definitions. Value Heal. 2008;11(1):44\u20137. https:\/\/doi.org\/10.1111\/j.1524-4733.2007.00213.x.","journal-title":"Value Heal"},{"key":"878_CR8","doi-asserted-by":"publisher","unstructured":"Misku Mohammed G, Abeje. Natnael Kebede TM& KA. Second-line antiretroviral therapy adherence and associated factors among adults living with HIV in Dessie City administration public hospitals, Northeast Ethiopia, Research Square. https:\/\/doi.org\/10.21203\/rs.3.rs-2465193\/v1, 2021. 2023;1\u201325.","DOI":"10.21203\/rs.3.rs-2465193\/v1"},{"issue":"5","key":"878_CR9","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1093\/cid\/ciy989","volume":"69","author":"A Esber","year":"2019","unstructured":"Esber A, Polyak C, Kiweewa F, Maswai J, Owuoth J, Maganga L, et al. Persistent Low-level Viremia Predicts Subsequent Virologic Failure: Is It Time to Change the Third 90? Clin Infect Dis. 2019;69(5):805\u201312.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"878_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0232703","volume":"15","author":"M Abadiga","year":"2020","unstructured":"Abadiga M, Hasen T, Mosisa G, Abdisa E. Adherence to antiretroviral therapy and associated factors among Human immunodeficiency virus positive patients accessing treatment at Nekemte referral hospital, west Ethiopia, 2019. PLoS ONE. 2020;15(5):1\u201314. https:\/\/doi.org\/10.1371\/journal.pone.0232703.","journal-title":"PLoS ONE"},{"issue":"7","key":"878_CR11","doi-asserted-by":"publisher","first-page":"e18279","DOI":"10.1016\/j.heliyon.2023.e18279","volume":"9","author":"MK Tariku","year":"2022","unstructured":"Tariku MK, Worede DT, Belete AH. Adherence to Antiretroviral Therapy and Associated Factors Among Human Immunodeficiency Virus Positive Patients Accessing Treatment at Health Centers in East Gojjam Zone, Northwest Ethiopia, 2019: Community Based Cross Sectional Study. SSRN Electron J. 2022;9(7):e18279. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e18279.","journal-title":"SSRN Electron J"},{"key":"878_CR12","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2147\/PPA.S298594","volume":"15","author":"AT Angelo","year":"2021","unstructured":"Angelo AT, Alemayehu DS. Adherence and its associated factors among adult hiv-infected patients on antiretroviral therapy in South Western Ethiopia, 2020. Patient Prefer Adherence. 2021;15:299\u2013308.","journal-title":"Patient Prefer Adherence"},{"issue":"1","key":"878_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12981-019-0238-y","volume":"16","author":"JM Leyva-Moral","year":"2019","unstructured":"Leyva-Moral JM, Loayza-Enriquez BK, Palmieri PA, Guevara-Vasquez GM, Elias-Bravo UE, Edwards JE, et al. Adherence to antiretroviral therapy and the associated factors among people living with HIV\/AIDS in Northern Peru: A cross-sectional study. AIDS Res Ther. 2019;16(1):1\u201312. https:\/\/doi.org\/10.1186\/s12981-019-0238-y.","journal-title":"AIDS Res Ther"},{"issue":"1","key":"878_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-019-7051-3","volume":"19","author":"S Neupane","year":"2019","unstructured":"Neupane S, Dhungana G, Ghimire H. Adherencia al tratamiento antirretroviral y factores asociados entre personas que viven con VIH y SIDA en CHITWAN, Nepal. BMC Public Health. 2019;19(1):1\u20139.","journal-title":"BMC Public Health"},{"issue":"4 April","key":"878_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0283991","volume":"18","author":"A Buh","year":"2023","unstructured":"Buh A, Deonandan R, Gomes J, Krentel A, Oladimeji O, Yaya S. Prevalence and factors associated with HIV treatment non-adherence among people living with HIV in three regions of Cameroon: A cross-sectional study. PLoS ONE. 2023;18(4 April):1\u201320. https:\/\/doi.org\/10.1371\/journal.pone.0283991.","journal-title":"PLoS ONE"},{"issue":"1","key":"878_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12981-021-00338-y","volume":"18","author":"H Musana","year":"2021","unstructured":"Musana H, Ssensamba JT, Nakafeero M, Mugerwa H, Kiweewa FM, Serwadda D, et al. Predictors of failure on second-line antiretroviral therapy with protease inhibitor mutations in Uganda. AIDS Res Ther. 2021;18(1):1\u201310. https:\/\/doi.org\/10.1186\/s12981-021-00338-y.","journal-title":"AIDS Res Ther"},{"issue":"1","key":"878_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12981-018-0214-y","volume":"16","author":"D Bukenya","year":"2019","unstructured":"Bukenya D, Mayanja BN, Nakamanya S, Muhumuza R, Seeley J. What causes non-adherence among some individuals on long term antiretroviral therapy? Experiences of individuals with poor viral suppression in Uganda. AIDS Res Ther. 2019;16(1):1\u20139. https:\/\/doi.org\/10.1186\/s12981-018-0214-y.","journal-title":"AIDS Res Ther"},{"issue":"1","key":"878_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12981-023-00544-w","volume":"20","author":"S Tuot","year":"2023","unstructured":"Tuot S, Sim JW, Nagashima-Hayashi M, Chhoun P, Teo AKJ, Prem K, et al. What are the determinants of antiretroviral therapy adherence among stable people living with HIV? A cross-sectional study in Cambodia. AIDS Res Ther. 2023;20(1):1\u201311.","journal-title":"AIDS Res Ther"},{"issue":"1","key":"878_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1057\/s41599-023-01982-7","volume":"10","author":"W Adefris","year":"2023","unstructured":"Adefris W, Damene S, Satyal P. Household practices and determinants of solid waste segregation in Addis Ababa city, Ethiopia. Humanit Soc Sci Commun. 2023;10(1):1\u201310.","journal-title":"Humanit Soc Sci Commun"},{"issue":"2","key":"878_CR20","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s10461-023-04252-4","volume":"28","author":"TM Aytenew","year":"2024","unstructured":"Aytenew TM, Demis S, Birhane BM, Asferie WN, Simegn A, Nibret G, et al. Non-Adherence to Anti-Retroviral Therapy Among Adult People Living with HIV in Ethiopia: Systematic Review and Meta-Analysis. AIDS Behav. 2024;28(2):609\u201324.","journal-title":"AIDS Behav"},{"key":"878_CR21","doi-asserted-by":"crossref","unstructured":"Jacqueline Bloomfield MJF. Quantitative research design. 22, J Australasian Rehabilitation Nurses Association. 2019.","DOI":"10.33235\/jarna.22.2.27-30"},{"key":"878_CR22","unstructured":"CRESWELL JW. Reaserch Design Qualitative, Quantitative and Mixed Methods Approaches. 4th ed. SAGE Publications Ltd; 2013;282."},{"key":"878_CR23","unstructured":"Federal Ministry of Health E. National Guidelines for Comprehensive Hiv Prevention, Care and Treatment Federal Minstry of Health. Fmoh. 2017;1\u2013225."},{"issue":"9","key":"878_CR24","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1002\/pds.5625","volume":"32","author":"SA Masresha","year":"2023","unstructured":"Masresha SA, Kidie AA, Alen GD, Mulaw GF, Feleke FW, Kassaw MW, et al. Virological failure and its predictors among human immunodeficiency virus infected individuals on second line antiretroviral treatment in North-East Ethiopia, 2021. Pharmacoepidemiol Drug Saf. 2023;32(9):978\u201387.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"878_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-022-07894-2","volume":"22","author":"S Salvi","year":"2022","unstructured":"Salvi S, Raichur P, Kadam D, Sangle S, Gupte N, Nevrekar N, et al. Virological failure among people living with HIV receiving second-line antiretroviral therapy in Pune, India. BMC Infect Dis. 2022;22(1):1\u20138. https:\/\/doi.org\/10.1186\/s12879-022-07894-2.","journal-title":"BMC Infect Dis"},{"key":"878_CR26","unstructured":"Ambaw G, Id K, Wolda GD, Woldegeorgis BZ, Gebrekidan AY, Haile KE et al. PLOS GLOBAL PUBLIC HEALTH Second-line anti-retroviral treatment failure and its predictors among patients with HIV in Ethiopia: A systematic review and meta- analysis. 2024;1\u201318."},{"key":"878_CR27","doi-asserted-by":"crossref","unstructured":"Julie H, Levison C, Orrell S, Gallien DR, Kuritzkes N, Fu E, Losina KA, Freedberg RW. Virologic Failure of Protease Inhibitor-Based Second-Line Antiretroviral Therapy without Resistance in a Large HIV Treatment Program in South Africa. 2012;7(3):3\u20137.","DOI":"10.1371\/journal.pone.0032144"},{"key":"878_CR28","doi-asserted-by":"crossref","unstructured":"Madiba S, Josiah U. Perceived Stigma and Fear of Unintended Disclosure are Barriers in Medication Adherence in Adolescents with Perinatal HIV in Botswana: A Qualitative Study. Biomed Res Int. 2019;2019.","DOI":"10.1155\/2019\/9623159"},{"issue":"1","key":"878_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13643-020-01524-1","volume":"9","author":"Y Lailulo","year":"2020","unstructured":"Lailulo Y, Kitenge M, Jaffer S, Aluko O, Nyasulu PS. Factors associated with antiretroviral treatment failure among people living with HIV on antiretroviral therapy in resource-poor settings: a systematic review and metaanalysis. Syst Rev. 2020;9(1):1\u201317.","journal-title":"Syst Rev"},{"issue":"7 July","key":"878_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0307656","volume":"19","author":"Q Wu","year":"2024","unstructured":"Wu Q, Tan J, Chen S, Wang J, Liao X, Jiang L. Incidence and influencing factors related to social isolation among HIV\/AIDS patients: Protocol for a systematic review and metaanalysis. PLoS ONE. 2024;19(7 July):1\u201310. https:\/\/doi.org\/10.1371\/journal.pone.0307656.","journal-title":"PLoS ONE"},{"key":"878_CR31","doi-asserted-by":"crossref","unstructured":"Nice J, Thurman TR, Luckett B, Zani B. Disclosure and Experiences of HIV-Related Stigma among Adolescents and Young Adults Living with HIV in South Africa. AIDS Behav. 2024;4158\u201366.","DOI":"10.1007\/s10461-024-04487-9"},{"issue":"10","key":"878_CR32","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.1007\/s10461-022-03610-y","volume":"26","author":"CD Agegnehu","year":"2022","unstructured":"Agegnehu CD, Techane MA, Mersha AT, Atalell KA. Burden and Associated Factors of Virological Failure Among People Living with HIV in Sub-Saharan Africa: A Systematic Review and Meta-Analysis. AIDS Behav. 2022;26(10):3327\u201336. https:\/\/doi.org\/10.1007\/s10461-022-03610-y.","journal-title":"AIDS Behav"},{"key":"878_CR33","doi-asserted-by":"crossref","unstructured":"Diress G, Dagne S, Alemnew B, Adane S, Addisu A. Viral Load Suppression after Enhanced Adherence Counseling and Its Predictors among High Viral Load HIV Seropositive People in North Wollo Zone Public Hospitals, Northeast Ethiopia, 2019: Retrospective Cohort Study. AIDS Res Treat. 2020;2020.","DOI":"10.1155\/2020\/8909232"},{"key":"878_CR34","doi-asserted-by":"publisher","unstructured":"Benjamin G, Id O, Id MI, Okwor E, Id BD, Brickson K et al. PLOS GLOBAL PUBLIC HEALTH Factors associated with viral load re- suppression after enhanced adherence counseling among people living with HIV with an initial high viral load result in selected Nigerian states. 2024;1\u201313. https:\/\/doi.org\/10.1371\/journal.pgph.0002876","DOI":"10.1371\/journal.pgph.0002876"},{"issue":"04","key":"878_CR35","first-page":"685","volume":"12","author":"AN Agbornkwai","year":"2022","unstructured":"Agbornkwai AN, Bita AIG, Mabouna SA, Esa I, Ngongheh AB, Ketum AS, et al. Enhanced Adherence Counselling, Support Groups and Viral Load Suppression amongst HIV-Positive Adolescents in a Tertiary Health Care Facility in Cameroon. Adv Infect Dis. 2022;12(04):685\u2013702.","journal-title":"Adv Infect Dis"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-026-00878-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-026-00878-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-026-00878-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:47:34Z","timestamp":1781570854000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12981-026-00878-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,12]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["878"],"URL":"https:\/\/doi.org\/10.1186\/s12981-026-00878-1","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,12]]},"assertion":[{"value":"18 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research went through a series of rigorous ethical approval processes before conducting the data collection as per the Helsinki Declaration. The research protocol got approval from UNISA (Ref. #: 20265433_CREC_CHS_2024) and the Addis Ababa Health Bureau (Ref.#: A\/A\/14641\/227). Moreover, to ensure the safety and validity of the research findings, the researcher adhered to fundamental ethical principles throughout the research process. These included obtaining permission, upholding participant autonomy, securing written informed consent, and ensuring beneficence, justice, non-maleficence, risk minimization, and strict confidentiality.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"63"}}